Source: Pharmacy Times articles
Artificial intelligence (AI) can transform rare disease research by leveraging patient data, enhancing evidence generation, and improving communication between patients and health care professionals.
Read More
by MM360 Staff | May 13, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Artificial intelligence (AI) can transform rare disease research by leveraging patient data, enhancing evidence generation, and improving communication between patients and health care professionals.
Read More